seatment of Hyperthyroidism 97 9. VanderLaan, W. P., Swenson, O.: The results of surgical treatment in Graves’ disease. N. Engl. J. Med. 236:236-238, 1947. 10. Beahrs, O. H.. Sakulsky, S. B.: Surgical thyroidectomy in the management of exophthalmic goiter. Arch. Surg. 96:512-516, 1968. 11. Hedley, A. J., Flemming, C. J., Chesters, M. I., et al.: Surgical treatment of thyrotoxicosis. Br. Med. J. 1:519-523, 1970. Hershman, J. M.: The treatmentof hyperthyroidism. Ann. Intern. Med. 64:1306-1314, 1966. 13. Goolden, A. W. G., Fraser, T. R.: Treatment of thyrotoxicosis with low doses of radioactive iodine. Br. Med. J. 2:442-443, 1969. 14. Bronsky, D., Kiamko, R. T., Waldstein, S. S.: Postherapeutic myxedema. Relative occurrence after treatment of hyperthyroidism by radioactive iodine (*'1) or subtotal . thyroidectomy. Arch. Intern. Med. 121:113-117, 1968. 15. Hagen, G. A., Ouelette, R. P., Chapman, E. M.: Comparison of high and low dosage ‘ levels of ‘I in the treatment of thyrotoxicosis. N. Engl. J. Med. 277:559-562, 1967. 16. Smith, R. N., Wilson, G. M.: Clinical trial of different doses of '*"I in treatment of thyrotoxicosis. Br. Med. J. 1:129-132, 1967. 17. Rapoport, B., Caplan, R., DeGroot, L. J.: Low-dose sodium iodide I 131 therapy in Graves’ disease. J.A.M.A. 224:1610-1613, 1973. 18. Jackson, G. L.: Calculated low dose radioiodine therapy of thyrotoxicosis. Int. J. Nucl. Med. Biol. 2:80-81, 1975. 19. Cevallos, J. L., Hagen, G. A., Maloof, F., et al.: Low-dosage 'I therapy of thyrotoxicosis (diffuse goiters). N. Engl. J. Med. 290:141-143, 1974. 20. Taylor, G. W., Painter, N. S.: Size of the thyroid remnantin partial thyroidectomy for toxic goitre. Lancet 1:287-289, 1962. 21. Whitsell, F. M., Black, B. M.: A statistical study of the clinical significance of lymphocytic and fibrocytic replacements in the hyperplastic thyroid gland. J. Clin. Endocrinol. Metabl. 9:1202-1215, 1949. 22. Burke, G., Silverstein, G. E.: Hypothyroidism after treatment with sodium iodide I 131. J.A.M.A. 210:1051-1058, 1969. 23. Einhorn, J., Einhorn, N., Fagraeus, A., et al.: Hypothyroidism and humoral an- tibodies after radioactive treatment of hyperthyroidism. In: Thyrotoxicosis, Proceed- 24. 25. > 26. 27. 28. 29. ings of an International Symposium, W. James Irvine (ed.). Baltimore, Williams & Wilkins Co., pp. 123-134, 1967. Blagg, C. R.: Antibodies to thyroglobulin in patients with thyrotoxicosis treated with radioactive iodine. Lancet 2:1364-1365, 1960. Buchanan, W. W., Koutras, D. A., Crooks, J., et al.: The clinical significance of the complement-fixation test in thyrotoxicosis. J. Endocrinol. 24:115-125, 1962. Irvine, W. J., Macgregor, A. G., Stuart, A. E.: The prognostic significance of thyroid antibodies in the managementof thyrotoxicosis. Lancet 2:843-847, 1962. Greig, W. R.: Radiation, thyroid cells and '*"I therapy—a hypothesis. J. Clin. Endocrinol. Metab. 25:1411-1417, 1965. Al-Hindawi, A. Y., Wilson, G. M.: The effect of irradiation on the function and survival of rat thyroid cells. Clin. Sci. 28:555-571, 1965. Volpé, R.: The immunologic basis of Graves’s disease. N. Engl. J. Med. 287:463—464, 1972. 30. Farid, N. R., Munro, R. E., Row, V. V., et al.: Peripheral thymus-dependent (T) lymphocytes in Graves’s disease and Hashimoto’s thyroiditis. N. Engl. J. Med. 288:1313-1317, 1973. 31. Lamki, L., Row, V. V., Volpé, R.: Cell-mediated immunity in Graves’ disease and in Hashimoto’s thyroiditis as shown by the demonstration of migration inhibition factor (MIF). J. Clin. Endocrinol. Metab. 36:358-364, 1973. Ge t So)2b02